AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Quarter 4; New/Revised ICD-10-CM Codes
Xylazine Toxicity
A 37-year-old patient was admitted for debridement of chronic ulcers of the right and left forearms. The ulcers expressed a copious purulent discharge with areas of necrosis of the subcutaneous tissue and muscle. The provider documented that the ulcers were due to injections of xylazine and fentanyl. What are the appropriate diagnosis code assignments for this inpatient encounter? ...
Subscribe or sign in to view the full article.
Article Overview
This article explains recent ICD-10-CM updates related to xylazine toxicity, including the creation of a new subcategory and related code options for different intent categories. It also summarizes the broader clinical context of xylazine exposure, including common routes of use and associated wound and infection concerns. The article is useful for inpatient coders, CDI specialists, compliance staff, and clinicians documenting substance-related toxic effects and complications.
Why This Topic Matters
Xylazine toxicity has emerged as a significant coding and documentation topic because it involves new diagnosis code selection, intent-based classification, and associated complications that may affect inpatient reporting. Understanding the article helps readers recognize when xylazine-related toxic effects and linked clinical findings are discussed in documentation.
What You Will Learn
- How xylazine toxicity is represented in ICD-10-CM
- What kinds of clinical complications are associated with xylazine exposure
- How the article frames the documentation context for inpatient diagnosis assignment
- Why intent and episode of care are relevant to this topic
Who Should Read This
- Medical coders
- Inpatient coders
- CDI specialists
- Compliance staff
- Clinicians
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com